The Tradr 2X Long ALAB Daily ETF (LABX) seeks to provide 200% of the daily performance of an underlying ALAB-related index or basket of securities. This leveraged thematic ETF targets companies involved in artificial intelligence, laboratory automation, biotechnology, or advanced laboratory technologies, amplifying both gains and losses through derivatives and swaps.
How It Works
LABX uses daily rebalancing to maintain 2x leveraged exposure through derivatives, swaps, and futures contracts rather than directly holding underlying securities. The fund resets its leverage ratio each trading day at market close, meaning it aims for 200% of single-day moves but compounds differently over multiple days. As a thematic ETF, it likely concentrates holdings in 20-50 companies within the laboratory automation and AI biotechnology sectors, creating significant sector concentration risk.
Key Features
- Provides 2x amplified daily exposure to emerging laboratory automation and AI biotechnology theme
- Daily rebalancing mechanism automatically adjusts leverage to maintain target 200% exposure ratio
- Recently launched in August 2025, offering early access to specialized ALAB investment theme
Risks
- This ETF can lose value rapidly due to daily compounding effects—if underlying drops 10% then rises 10%, the fund does not return to break-even
- Concentrated thematic exposure means 30-50% declines possible if laboratory automation sector falls out of favor or faces regulatory challenges
- Leveraged structure amplifies all movements, potentially causing 40-80% losses during broader market downturns affecting technology and biotech sectors
Who Should Own This
Suitable only for sophisticated traders with high risk tolerance and holding periods of days to weeks maximum. Requires active monitoring and represents speculative satellite allocation of 1-5% maximum. Not appropriate for buy-and-hold investors or retirement accounts due to daily reset compounding effects and extreme volatility potential.